1. Home
  2. RVMD vs VST Comparison

RVMD vs VST Comparison

Compare RVMD & VST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

SELL

Current Price

$193.42

Market Cap

40.3B

Sector

Health Care

ML Signal

SELL

Logo Vistra Corp.

VST

Vistra Corp.

SELL

Current Price

$151.43

Market Cap

47.0B

Sector

Utilities

ML Signal

SELL

Company Overview

Basic Information
Metric
RVMD
VST
Founded
2014
1882
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
40.3B
47.0B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
RVMD
VST
Price
$193.42
$151.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
24
21
Target Price
★ $259.14
$210.25
AVG Volume (30 Days)
2.2M
★ 5.5M
Earning Date
11-04-2026
11-06-2026
Dividend Yield
N/A
★ 0.57%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 3.64
Revenue
N/A
★ $17,738,000,000.00
Revenue This Year
N/A
$26.76
Revenue Next Year
$564.95
$7.35
P/E Ratio
★ N/A
$44.60
Revenue Growth
N/A
★ 2.98
52 Week Low
$49.05
$132.66
52 Week High
$224.31
$217.10

Technical Indicators

Market Signals
Indicator
RVMD
VST
Relative Strength Index (RSI) 44.06 52.17
Support Level $188.18 $151.09
Resistance Level $194.19 $154.02
Average True Range (ATR) 8.63 7.33
MACD -1.27 1.49
Stochastic Oscillator 41.68 47.47

Price Performance

Historical Comparison
RVMD
VST

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About VST Vistra Corp.

Vistra Corp. is one of the largest power producers and retail energy providers in the US. It owns 44 gigawatts of generation capacity, including natural gas (27 GW), nuclear (6.5 GW), coal (8.7 GW), and solar and battery storage (1.3 GW). The Cogentrix acquisition will add 5.5 GW of gas generation. Vistra's retail electricity business serves 5 million customers in 20 states, including almost a third of all Texas electricity consumers. Vistra emerged from the Energy Future Holdings bankruptcy as a stand-alone entity in 2016.

Share on Social Networks: